You are here: Industry Insights > API

News List

Eurofins CDMO Expands Drug Product Capabilities in Canada contractpharma
November 06, 2020
?Eurofins CDMO has expanded its existing drug product operation capabilities with the early 2020 completion of its new drug product development and cGMP manufacturing facility, located in Mississauga, Canada.
Lasa gets environmental clearance for benzimidazole derivatives capacity expansion at Khed facility expresspharma
November 06, 2020
Lasa’s total volumetric capacity to increase by ~60 per cent to 6,800 TPA.
Reducing API dependence: Have we got the strategy right? expresspharma
November 04, 2020
Reji K Joseph, Associate Professor, Institute for Studies in Industrial Development, New Delhi explains that the PLI scheme has some gaps that need to be plugged for it to be truly successful.
Pharma industry appreciates modification in PLI scheme, seek more support expresspharma
November 02, 2020
The industry also raises concerns related to brownfield investments, protection of indigenous manufacturing.
Aarti Drugs to expand metformin capacity to 3000 TPM expresspharma
November 02, 2020
Aarti Drugs has procured land to expand its existing Metformin Capacity to 3000 TPM in a brownfield expansion. This expansion would be a two-phase expansion program.
CordenPharma Colorado Completes Highly Potent API Lab Expansion contractpharma
October 21, 2020
?CordenPharma has completed a new highly potent active pharmaceutical ingredient (API) laboratory in its Boulder, CO, facility.
Biopharma companies more optimistic about 2020 imports/exports than in Q1: GlobalData expresspharma
October 19, 2020
API manufacturing still remains a greater concern than finished dose due to the high volume of small molecule API produced in China and India for cost reasons.
More than APIs, Indian pharma industry needs to reduce dependency on drug intermediates: Premchand Godha expresspharma
October 10, 2020
Policies, schemes should be designed keeping overall drug industry in mind, said the Chairman and MD of Ipca Laboratories.
Majority of generic drug ingredients produced in Asia – study expresspharma
October 10, 2020
Industry players warn bringing production home may be a complicated process, saying higher labour costs and tougher environmental standards make it impossible to compete with Asian suppliers on price.
Research finds 25 percent of drugs contain highly potent compounds europeanpharmaceuticalreview
September 27, 2020
A new report has said that a quarter of drugs globally are based on highly potent active pharmaceutical ingredients.